The preventive effect of low-dose aspirin in a PPAR-γ antagonist treated mouse model of preeclampsia

BACKGROUND: Preeclampsia (PE) is one of the leading causes of maternal and perinatal mortality and morbidity. Low-dose aspirin (LDA) is the most widely used drug to prevent PE, but the recommended dose of LDA varies according to different guidelines. Peroxisome proliferator-activated receptor (PPAR)...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Yongbing, Zhu, Yuchun, Sun, Yu, Yang, Huixia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338524/
https://www.ncbi.nlm.nih.gov/pubmed/35906540
http://dx.doi.org/10.1186/s12884-022-04901-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338524/
https://www.ncbi.nlm.nih.gov/pubmed/35906540
http://dx.doi.org/10.1186/s12884-022-04901-x

Ejemplares similares